News

Filter

Termination of Shigamabs deal with LFB Biotech leads Thallion to review options

21-02-2013

Canada-based Thallion Pharmaceuticals (TSX VENTURE: TLN) and LFB Biotechnologies of France have terminated…

Antibiotics and Infectious diseasesBiotechnologyLFB BiotechnologiesLicensingShigamabsThallion Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top